Home
Home

Ampio

Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?

Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?
Seeking Alpha

Ampio's New Anti-Inflammatory Drug May Achieve Rapid FDA Clearance

Ampio's New Anti-Inflammatory Drug May Achieve Rapid FDA Clearance
Seeking Alpha

Top Ampio Pharma execs extend lock-up agreement

Top Ampio Pharma execs extend lock-up agreement
Yahoo/AP

Ampio rises on plans for second version of Zertane

Ampio rises on plans for second version of Zertane
Yahoo/AP

Ampio Reports Successful Type B Pre-IND Meeting with the FDA for its Drug Zertane™ to treat Premature Ejaculation

Ampio Reports Successful Type B Pre-IND Meeting with the FDA for its Drug Zertane™ to treat Premature Ejaculation
BioMedReports

Ampio eye drug meets study goal, shares soar

Ampio eye drug meets study goal, shares soar
Reuters

Ampio announecs extended analysis of Ampion in knee shows pain relief

Ampio announecs extended analysis of Ampion in knee shows pain relief
The Fly on the Wall

Ampio Pharmaceuticals Follows Multiple Pipeline Strategies With Potential

Ampio Pharmaceuticals Follows Multiple Pipeline Strategies With Potential
Seeking Alpha

Why Ampio's Big Rebound Run May Not Be Done

Why Ampio's Big Rebound Run May Not Be Done
Seeking Alpha

Ampio: On The Trail Of An Osteoarthritis Winner

Ampio: On The Trail Of An Osteoarthritis Winner
Seeking Alpha